PL374544A1 - Związki imidazo-skondensowane - Google Patents
Związki imidazo-skondensowaneInfo
- Publication number
- PL374544A1 PL374544A1 PL03374544A PL37454403A PL374544A1 PL 374544 A1 PL374544 A1 PL 374544A1 PL 03374544 A PL03374544 A PL 03374544A PL 37454403 A PL37454403 A PL 37454403A PL 374544 A1 PL374544 A1 PL 374544A1
- Authority
- PL
- Poland
- Prior art keywords
- fused compounds
- imidazo
- imidazo fused
- compounds
- fused
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36992902P | 2002-04-03 | 2002-04-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL374544A1 true PL374544A1 (pl) | 2005-10-31 |
Family
ID=28675587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03374544A PL374544A1 (pl) | 2002-04-03 | 2003-03-27 | Związki imidazo-skondensowane |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US6949560B2 (pl) |
| EP (1) | EP1492790A1 (pl) |
| JP (1) | JP2006503802A (pl) |
| KR (1) | KR100656205B1 (pl) |
| CN (1) | CN1293078C (pl) |
| AR (1) | AR039219A1 (pl) |
| AU (1) | AU2003215675B2 (pl) |
| BR (1) | BR0308937A (pl) |
| CA (1) | CA2479644A1 (pl) |
| MX (1) | MXPA04009585A (pl) |
| PL (1) | PL374544A1 (pl) |
| RU (1) | RU2310657C2 (pl) |
| WO (1) | WO2003082871A1 (pl) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050070554A1 (en) * | 2003-08-27 | 2005-03-31 | Amgen Inc. | Substituted heterocyclic compounds and methods of use |
| DE10361659A1 (de) | 2003-12-30 | 2005-07-28 | Osram Opto Semiconductors Gmbh | Verfahrem zum Herstellen einer epitaktischen Bauelementschichtenfolge und optoelektronischer Halbleiterchip |
| FR2873118B1 (fr) * | 2004-07-15 | 2007-11-23 | Sanofi Synthelabo | Derives de pyrido-pyrimidine, leur application en therapeutique |
| CA2681420A1 (en) * | 2007-03-20 | 2008-09-25 | Cadila Pharmaceuticals Limited | P38 inhibitors |
| WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
| SG11201400988SA (en) * | 2011-10-21 | 2014-07-30 | Glaxosmithkline Llc | Compounds and methods for enhancing innate immune responses |
| CA2876689C (en) | 2012-06-13 | 2022-04-26 | Incyte Corporation | Substituted tricyclic compounds as fgfr inhibitors |
| US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
| US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
| PH12015502383B1 (en) | 2013-04-19 | 2023-02-03 | Incyte Holdings Corp | Bicyclic heterocycles as fgfr inhibitors |
| CN105481858B (zh) * | 2014-10-11 | 2019-05-17 | 上海医药集团股份有限公司 | 一种含氮稠杂环化合物、其制备方法、组合物及应用 |
| US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| CA2976790C (en) | 2015-02-20 | 2024-02-27 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| DK3368052T3 (da) | 2015-10-27 | 2022-03-14 | Childrens Hospital Med Ct | Anvendelse af mapk-hæmmere for at nedbringe tabet af hæmatopoietiske stamceller under ex vivo-dyrkning og -genmanipulation |
| US20190060286A1 (en) | 2016-02-29 | 2019-02-28 | University Of Florida Research Foundation, Incorpo | Chemotherapeutic Methods |
| WO2018004258A1 (ko) * | 2016-06-28 | 2018-01-04 | 한미약품 주식회사 | 신규한 헤테로시클릭 유도체 화합물 및 이의 용도 |
| KR20180002053A (ko) * | 2016-06-28 | 2018-01-05 | 한미약품 주식회사 | 신규한 헤테로시클릭 유도체 화합물 및 이의 용도 |
| CA3043945A1 (en) * | 2016-11-16 | 2018-05-24 | Sui Xiong Cai | 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6h)-ones |
| JP6876833B2 (ja) * | 2017-02-27 | 2021-05-26 | ▲貝▼▲達▼▲薬▼▲業▼股▲フン▼有限公司Betta Pharmaceuticals Co., Ltd. | Fgfr阻害剤およびその使用 |
| CN109923115B (zh) * | 2017-05-23 | 2021-06-01 | 晟科药业(江苏)有限公司 | 咪唑并[1’,2’:1,6]吡啶并[2,3-d]嘧啶类化合物作为蛋白激酶抑制剂 |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| ES2927715T3 (es) | 2017-10-05 | 2022-11-10 | Fulcrum Therapeutics Inc | Inhibidores de la quinasa p38 reducen la expresión de dux4 y de los genes que le siguen para el tratamiento de la FSHD |
| CN109721600B (zh) * | 2017-10-30 | 2021-04-27 | 上海凌达生物医药有限公司 | 一类含氮稠环化合物及其制备方法和用途 |
| CN109721599B (zh) * | 2017-10-30 | 2020-12-15 | 上海凌达生物医药有限公司 | 一类氨基取代含氮稠环化合物及其制备方法和用途 |
| RS66310B1 (sr) | 2018-05-04 | 2025-01-31 | Incyte Corp | Čvrsti oblici inhibitora fgfr i procesi za njegovu pripremu |
| KR102956194B1 (ko) | 2018-05-04 | 2026-04-23 | 인사이트 코포레이션 | Fgfr 억제제의 염 |
| CN110857300B (zh) * | 2018-08-23 | 2021-11-05 | 上海凌达生物医药有限公司 | 一类稠环三氮唑类化合物、制备方法和用途 |
| CN112654623B (zh) * | 2018-08-27 | 2023-05-23 | 贝达药业股份有限公司 | 新型氮杂三环类化合物的盐型、晶型及其用途 |
| US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
| WO2020168197A1 (en) | 2019-02-15 | 2020-08-20 | Incyte Corporation | Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors |
| TW202100520A (zh) | 2019-03-05 | 2021-01-01 | 美商英塞特公司 | 作為cdk2 抑制劑之吡唑基嘧啶基胺化合物 |
| EP3936509B1 (en) * | 2019-03-08 | 2024-07-31 | Shouyao Holdings (Beijing) Co., Ltd. | Fgfr4 kinase inhibitor, preparation method therefor and use thereof |
| WO2020185532A1 (en) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Methods of treating cancer with an fgfr inhibitor |
| US11919904B2 (en) | 2019-03-29 | 2024-03-05 | Incyte Corporation | Sulfonylamide compounds as CDK2 inhibitors |
| WO2020223469A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer |
| WO2020223558A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | Tricyclic amine compounds as cdk2 inhibitors |
| WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| WO2021030537A1 (en) | 2019-08-14 | 2021-02-18 | Incyte Corporation | Imidazolyl pyrimidinylamine compounds as cdk2 inhibitors |
| US12122767B2 (en) | 2019-10-01 | 2024-10-22 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| CR20220170A (es) | 2019-10-11 | 2022-10-10 | Incyte Corp | Aminas bicíclicas como inhibidoras de la cdk2 |
| GEP20247679B (en) | 2019-10-14 | 2024-10-10 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors |
| US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| MX2022006691A (es) | 2019-12-04 | 2022-09-19 | Incyte Corp | Derivados de un inhibidor de receptores del factor de crecimiento de fibroblastos (fgfr). |
| WO2021113479A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| US12012409B2 (en) | 2020-01-15 | 2024-06-18 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| US20230303570A1 (en) * | 2020-08-07 | 2023-09-28 | Abm Therapeutics Corporation | Kinase inhibitors and uses thereof |
| EP4323405A1 (en) | 2021-04-12 | 2024-02-21 | Incyte Corporation | Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent |
| TW202313610A (zh) | 2021-06-09 | 2023-04-01 | 美商英塞特公司 | 作為fgfr抑制劑之三環雜環 |
| CA3220274A1 (en) | 2021-06-09 | 2022-12-15 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| US11981671B2 (en) | 2021-06-21 | 2024-05-14 | Incyte Corporation | Bicyclic pyrazolyl amines as CDK2 inhibitors |
| US11976073B2 (en) | 2021-12-10 | 2024-05-07 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522947A (en) | 1982-03-29 | 1985-06-11 | Usv Pharmaceutical Corporation | Certain 1,3-oxazolo[4,5H]quinolines useful as anti-allergy agents |
| US4656281A (en) | 1983-03-18 | 1987-04-07 | Usv Pharmaceutical Corp. | Imidazo quinoline compounds useful as anti-allergy agents |
| DE3502689A1 (de) | 1985-01-26 | 1986-07-31 | Hoechst Ag, 6230 Frankfurt | Elektrophotographisches aufzeichnungsmaterial |
| US4831040A (en) | 1988-02-01 | 1989-05-16 | Rorer Pharmaceutical Corporation | Method of prevention and treatment of peptic ulcers |
| GB9123916D0 (en) | 1991-11-11 | 1992-01-02 | Wellcome Found | Heterocyclic compounds |
| DE19510965A1 (de) * | 1995-03-24 | 1996-09-26 | Asta Medica Ag | Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung |
| JPH11292878A (ja) | 1998-04-09 | 1999-10-26 | Yamanouchi Pharmaceut Co Ltd | イミダゾナフチリジン誘導体 |
| DE60033307T2 (de) * | 1999-10-21 | 2007-07-12 | F. Hoffmann-La Roche Ag | Heteroalkylamino-substituierte bicyclische stickstoffheterocyclen als p38-proteinkinase-inhibitoren |
| KR100571339B1 (ko) * | 2000-08-31 | 2006-04-17 | 에프. 호프만-라 로슈 아게 | 세포증식 억제제로서의 7-옥소 피리도피리미딘 |
| SK11322003A3 (en) | 2001-02-12 | 2004-10-05 | Hoffmann La Roche | 6-Substituted pyrido-pyrimidines |
-
2003
- 2003-03-27 RU RU2004132204/04A patent/RU2310657C2/ru active
- 2003-03-27 JP JP2003580336A patent/JP2006503802A/ja active Pending
- 2003-03-27 BR BR0308937-1A patent/BR0308937A/pt not_active IP Right Cessation
- 2003-03-27 EP EP03745276A patent/EP1492790A1/en not_active Withdrawn
- 2003-03-27 CN CNB038075369A patent/CN1293078C/zh not_active Expired - Fee Related
- 2003-03-27 KR KR1020047015609A patent/KR100656205B1/ko not_active Expired - Fee Related
- 2003-03-27 WO PCT/EP2003/003178 patent/WO2003082871A1/en not_active Ceased
- 2003-03-27 PL PL03374544A patent/PL374544A1/pl not_active Application Discontinuation
- 2003-03-27 CA CA002479644A patent/CA2479644A1/en not_active Abandoned
- 2003-03-27 AU AU2003215675A patent/AU2003215675B2/en not_active Ceased
- 2003-03-27 MX MXPA04009585A patent/MXPA04009585A/es active IP Right Grant
- 2003-04-02 AR ARP030101141A patent/AR039219A1/es unknown
- 2003-04-03 US US10/406,364 patent/US6949560B2/en not_active Expired - Fee Related
-
2005
- 2005-05-04 US US11/122,137 patent/US7081462B2/en not_active Expired - Fee Related
-
2006
- 2006-07-13 US US11/486,193 patent/US7285559B2/en not_active Expired - Fee Related
- 2006-07-13 US US11/486,348 patent/US7285561B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1293078C (zh) | 2007-01-03 |
| EP1492790A1 (en) | 2005-01-05 |
| KR100656205B1 (ko) | 2006-12-12 |
| US20060252783A1 (en) | 2006-11-09 |
| WO2003082871A1 (en) | 2003-10-09 |
| US20050197352A1 (en) | 2005-09-08 |
| US7285559B2 (en) | 2007-10-23 |
| US20030232847A1 (en) | 2003-12-18 |
| MXPA04009585A (es) | 2005-01-11 |
| US20060252784A1 (en) | 2006-11-09 |
| JP2006503802A (ja) | 2006-02-02 |
| BR0308937A (pt) | 2005-01-04 |
| CA2479644A1 (en) | 2003-10-09 |
| US7081462B2 (en) | 2006-07-25 |
| US7285561B2 (en) | 2007-10-23 |
| CN1646529A (zh) | 2005-07-27 |
| RU2004132204A (ru) | 2005-11-20 |
| KR20040099384A (ko) | 2004-11-26 |
| US6949560B2 (en) | 2005-09-27 |
| AU2003215675A1 (en) | 2003-10-13 |
| AU2003215675B2 (en) | 2007-07-12 |
| AR039219A1 (es) | 2005-02-09 |
| RU2310657C2 (ru) | 2007-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL375935A1 (pl) | Pochodne skondensowanych azolopirymidyn | |
| HUS1600008I1 (hu) | Cefémvegyületek | |
| IL164958A0 (en) | Carbamate-substituted pyrazolopyridines | |
| EP1687002A4 (en) | CONDENSED HETEROCYCLIC COMPOUNDS | |
| IL174283A0 (en) | Fused heterocyclic compounds | |
| EP1558585A4 (en) | NEUROLOGICALLY ACTIVE COMPOUNDS | |
| EP1569644A4 (en) | INDOLIZINE COMPOUNDS | |
| GB0200283D0 (en) | Compounds | |
| MY143373A (en) | Novel fused pyrrolocarbazoles | |
| MY142713A (en) | Novel fused pyrrolocarbazoles | |
| PL372989A1 (pl) | Triazolopirymidyny | |
| GB0218147D0 (en) | Novel compounds | |
| PL376659A1 (pl) | Skondensowane związki heterocykliczne | |
| AU2003216859A8 (en) | Amidoacetonitrile compounds | |
| IL161836A0 (en) | Aryl fused azapolycyclic compounds | |
| GB0207323D0 (en) | Compounds | |
| GB0203778D0 (en) | Compounds | |
| AU2003275480A8 (en) | Compounds | |
| GB0203811D0 (en) | Compounds | |
| GB0217850D0 (en) | Fused socket | |
| GB0206981D0 (en) | Compounds | |
| GB0207270D0 (en) | Compounds | |
| AU2003274754A8 (en) | Cephem compounds | |
| GB0203186D0 (en) | Compounds | |
| GB0202026D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |